论文信息 - Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High‐Dose Propranolol - 字舞流文

Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High‐Dose Propranolol

Diffuse hepatic hemangiomas are a challenging disease that can be life threatening. We present the case of an infant with diffuse hepatic hemangiomas who failed first‐line therapies but later responded to sirolimus and high‐dose propranolol.

M. Levy | L. Diaz | Donald Warren

[1] D. Zurakowski,et al. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. , 2015, Journal of pediatric surgery.

[2] A. Theos,et al. Treatment of Infantile Hemangiomas with Sirolimus in a Patient with PHACE Syndrome , 2013, Pediatric dermatology.

[3] E. Boscolo,et al. Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile Hemangioma , 2011, The Journal of investigative dermatology.

[4] C. Bodemer,et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. , 2010, The Journal of pediatrics.

[5] J. Mulliken,et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. , 1996, The Journal of pediatrics.